NOD-scid IL2R γnull mice were engrafted with hPBMC derived from patients suffering from AD and from healthy volunteers and treated with IL-4 or the IL-4 antagonist/inhibitor Pitrakinra. Here, IL4 is linked to Alzheimer disease.